Mean | SD | Frequency | Mean share of total OOPs | SD | |
---|---|---|---|---|---|
Individuals who used care (n1 = 2412) | |||||
Aggregate costs (mean, sd, n, %) | |||||
Overall reported cost | 6.20 | 0.35 | 100.0% | naa | na |
Care users who spent >USD 0 (n2 = 2168) | |||||
Aggregate costs (mean, sd, n, %) | |||||
Overall reported OOPs | 6.77 | 0.37 | 100.0% | na | na |
Overall reported cost, per visit | 6.61 | 0.37 | 100.0% | na | na |
Itemized OOPs | |||||
Total medical cost, per visit | 6.37 | 0.38 | 100.0% | 97.7% | 0.9% |
Drugs and medicines | 4.90 | 0.34 | 99.7% | 62.3% | 8.9% |
Consultation | 2.33 | 0.27 | 74.9% | 32.7% | 9.0% |
Laboratory tests | 1.05 | 0.12 | 38.5% | 1.4% | 0.5% |
X-ray | 0.63 | 0.26 | 14.1% | 0.8% | 0.4% |
Medical products | 0.02 | 0.01 | 13.2% | 0.5% | 0.2% |
Total non-medical cost, per visit | 2.71 | 0.58 | 7.6% | 2.3% | 0.9% |
Transportation | 0.45 | 0.22 | 15.0% | 0.7% | 0.3% |
Other | 0.64 | 0.12 | 19.9% | 1.6% | 0.7% |
Health sector | |||||
Public medical | 7.00 | 9.39 | 67.3% | na | na |
Private medical | 7.30 | 12.76 | 25.2% | na | na |
Informal | 3.93 | 8.28 | 7.5% | na | na |
Excessive OOPs analysis groups | |||||
Low (<p50) | 1.31 | 0.69 | 37.7% | na | na |
Medium-high (≥p50) | 3.89 | 0.82 | 27.7% | na | na |
High (≥ 2 times p50) | 6.87 | 0.80 | 13.5% | na | na |
Extremely high (≥ 3 times p50) | 21.66 | 15.28 | 21.1% | na | na |
Setting | |||||
Rural | 6.40 | 9.61 | 88.1% | na | na |
Urban | 10.88 | 16.15 | 11.9% | na | na |
Study areas | |||||
Equateur | 4.44 | 6.02 | 26.2% | na | na |
Kasai-Occidental / Oriental | 5.82 | 10.25 | 36.8% | na | na |
Maniema / Orientale | 9.69 | 11.58 | 37.0% | na | na |
Gender | |||||
Female | 7.07 | 10.58 | 55.1% | na | na |
Male | 6.26 | 10.07 | 44.9% | na | na |
Health insurance status | |||||
Covered, any scheme | 8.53 | 16.28 | 3.9% | na | na |
Mutual health organization | 5.22 | 7.80 | 86.6% | na | na |
Employer-offered plan | 19.39 | 29.23 | 12.2% | na | na |
Other commercial plan | 6.00 | na | 1.2% | na | na |
Uncovered | 6.70 | 10.28 | 96.1% | na | na |